Tag: Germany
Germany Market Review, Q3 2024: investors go risk on as rates fall
Europe | Market Reviews
25 Oct 2024 by Viktor Radushev
Falling rates see investors move further away from capital protection
German structured products market rides the wave
Europe | Products
27 Jun 2024 by SRP News
The latest statistics from the Bundesverband für Strukturierte Wertpapiere (BSW) show that the structured products market continues its upward trend in Germany despite a slight decrease in the total volume traded compared to March.
Spectrum complements leverage range with pure trackers, equities to follow
Europe | Industry
11 Jun 2024 by Pablo Conde
Pan-European trading venue Spectrum Markets has announced today the listing of 1,757 exchange traded funds (ETFs) for trading.
Germany Market Review, Q1 2024: issuance, sales post record high
Europe | Market Reviews
13 May 2024 by Viktor Radushev
The German market has set a new record for both issuance and sales with Landesbank Baden-Württemberg (LBBW) taking over DekaBank in league table's leading spot as capital protected products surged amidst changes in top performing underlyings.
Top issuers Europe 2023: JPM’s flow products increase visibility in Germany
Europe | Industry
11 Dec 2023 by Summer Wang
As we approach the end of 2023 we look at the most active issuers across the main European markets based on SRP data.
Dax – barometer for the German economy
Europe | Indices
11 Jul 2023 by SRP News
The value of the German benchmark has increased 12.5-fold since its launch in 1988.
J.P. Morgan reports Russia related losses, strong Q1 for US structured products
International | Industry
20 Apr 2022 by SRP News
Despite the positive performance the US investment bank reported losses related to markdowns of derivatives receivables from counterparties linked to Russia in Q1 2022.
Pharma in structured products (part 2) - stagnating issuance in main pharma markets
International | Products
23 Mar 2021 by Filip Dyankov
Buoyant issuance in Malaysia, Belgium and France; reverse convertibles linked to pharma companies have been less affected than growth products, notably the leverage long with stop loss; US breakdown – CVS Health losing ground in sales, Merck records sustained growth.
Germany: main distribution outlets stay strong despite headwinds
Europe | Industry
03 Dec 2019 by Pablo Conde and Suzanna Moni
In the second of a three part series covering the most recent developments in the German market, SRP looks at the main distributors, the market trends, and what the main players expect in the short-term.
